CONMED CORPORATION Debt Related Commitment Fees and Debt Issuance Costs
CONMED CORPORATION (CNMD) reported Debt Related Commitment Fees and Debt Issuance Costs of $3.60 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts · last filed 2022-02-22
- CONMED CORPORATION debt related commitment fees and debt issuance costs for the quarter ending 2019-12-31 was $0.00.
- CONMED CORPORATION debt related commitment fees and debt issuance costs for the quarter ending 2019-09-30 was $0.00.
- CONMED CORPORATION debt related commitment fees and debt issuance costs for the quarter ending 2019-06-30 was $0.00.
- CONMED CORPORATION debt related commitment fees and debt issuance costs for the quarter ending 2019-03-31 was $3.60M.
- CONMED CORPORATION debt related commitment fees and debt issuance costs for fiscal 2019 was $3.60M.
- CONMED CORPORATION debt related commitment fees and debt issuance costs for fiscal 2016 was $2.70M.
| Period end | Debt Related Commitment Fees and Debt Issuance Costs 3 month | Debt Related Commitment Fees and Debt Issuance Costs 6 month | Debt Related Commitment Fees and Debt Issuance Costs 9 month | Debt Related Commitment Fees and Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $3.60M 10-K · filed 2022-02-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $3.60M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $3.60M 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $3.60M 10-Q · filed 2020-04-30 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $0.00 derived: sum of 2 quarters · filed 2019-02-25 | $0.00 derived: sum of 3 quarters · filed 2019-02-25 | $2.70M 10-K · filed 2019-02-25 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $2.70M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-K 3 month · filed 2017-07-27 | $2.70M 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $2.70M 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |